Centre Algerois de Pediatrie, Pediatric gastroenterology, Algiers, Algeria.
Institut National de Santé Publique, Unité santé et environnement, Algiers, Algeria.
J Asthma. 2022 Jun;59(6):1169-1176. doi: 10.1080/02770903.2021.1917606. Epub 2021 May 5.
The role of gastro-esophageal reflux disease (GERD) in poorly controlled asthma is often mentioned, but published studies have presented discordant results. Our main objective was to assess the effectiveness of GERD treatment in controlling asthma in children.
We conducted a prospective study including poorly controlled asthmatic children aged 4 to 16 years. We checked the presence of acid reflux using pH monitoring. Patients with GERD were randomized into two groups; one received omeprazole for 6 months and the control group was not treated. The outcome was the score of the children asthma control test at the end of 6 months. The acid suppression was checked at the end of treatment with pH monitoring. After treatment, children with persistent acid reflux received high PPI doses and therefore were reevaluated 6 months later.
We included 102 children with poorly controlled asthma among which 59 (57.8%) had acid reflux. Gastroesophageal reflux (GER) was significantly more common in boys ( = 0.04). Treatment with omeprazole in sufficient doses improved the control of asthma in 5 children out of 6 (84.8 vs 11.5; <.0001). Three factors appeared to be statistically associated with asthma control improvement after PPI therapy: male sex (=.04), normal birth weight (=.05) and a positive Prick-test (=.05). These factors were not confirmed or were not sufficiently precise in multivariate analysis. The likelihood of a causal relationship between acid reflux and asthma, difficult to highlight with pH monitoring, was poor.
This study confirmed the high prevalence of GER in poorly controlled asthmatic children and showed the possible benefit of an efficient GER treatment in improving asthma control.
胃食管反流病(GERD)在控制不佳的哮喘中的作用经常被提及,但已发表的研究结果存在差异。我们的主要目的是评估 GERD 治疗在控制儿童哮喘中的效果。
我们进行了一项前瞻性研究,纳入了年龄在 4 至 16 岁之间的控制不佳的哮喘患儿。我们使用 pH 监测检查酸反流的存在。GERD 患者被随机分为两组;一组接受奥美拉唑治疗 6 个月,对照组未接受治疗。主要结局是 6 个月后儿童哮喘控制测试的评分。治疗结束时,使用 pH 监测检查酸抑制情况。治疗后,持续性酸反流的患儿接受高剂量的 PPI 治疗,并在 6 个月后再次进行评估。
我们纳入了 102 例控制不佳的哮喘患儿,其中 59 例(57.8%)存在酸反流。男孩中 GER 更为常见( = 0.04)。足够剂量的奥美拉唑治疗改善了 6 例患儿中的 5 例(84.8%比 11.5%;<.0001)的哮喘控制情况。3 个因素在 PPI 治疗后与哮喘控制改善有关:男性( = 0.04)、正常出生体重( = 0.05)和皮试阳性( = 0.05)。这些因素在多变量分析中未得到证实或不够精确。pH 监测很难确定酸反流和哮喘之间的因果关系,其可能性较低。
本研究证实了控制不佳的哮喘患儿中 GER 的高患病率,并表明有效的 GER 治疗可能改善哮喘控制。